Breaks Categories: News

ThursdayFeb 29, 2024 2:19 pm

NetworkNewsBreaks – Zoned Properties Inc. (ZDPY) Moves to Grow Investment Portfolio with Strategic Acquisition, Lease Agreement for Arizona-Based Property

Zoned Properties (OTCQB: ZDPY), a leading real estate development firm for emerging and highly regulated industries, including legalized cannabis, today announced its receipt of final cannabis approvals related to an investment property in Surprise, Arizona. The company is under contract to acquire the property upon completion of initial site work by the selling developer. In addition, Zoned Properties has entered into a long-term, absolute-net lease agreement with a best-in-class Arizona cannabis company, Sunday Goods, to operate a retail dispensary. “Arizona’s cannabis market stands out as one of the most dynamic and consumer-driven in the United States. The strongest brands in…

Continue Reading

ThursdayFeb 29, 2024 2:11 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Begins Road Testing on Solid-State Polymer Battery Pack

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has moved to the next phase in testing an integrated solid-state polymer battery pack in its Class 1 EV cargo vans. According to the announcement, vehicle road testing began this week on the battery pack. The company began initial lab testing of the latest phase of solid-state polymer battery packs in January by installing the battery pack in the Class 1 EV cargo van to monitor system compatibility between the vehicle and pack; performance testing also included on-road drive cycles and Dyno testing at an EPA-certified lab. The company initially…

Continue Reading

ThursdayFeb 29, 2024 1:57 pm

NetworkNewsBreaks – Premier Products Group Inc. (OTC: PMPG) Interim CEO Releases Letter to Shareholders

Premier Products Group (OTC: PMPG) has issued a letter to shareholders from interim CEO Terry L Stein. In the letter, Stein noted that the company has been trading on the “expert market” because of prior management’s failure to ensure that required filings were kept up to date, meaning that access to securities are only available to broker-dealers, professionals and sophisticated investors. Consequently, Stein filed a default against the management group and took over voting control of the company in an effort to protect shareholders and become compliant with the U.S. Securities Commission (“SEC”). The process has been time consuming, but Stein…

Continue Reading

ThursdayFeb 29, 2024 1:20 pm

NetworkNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Welcomes Second Native American Tribal Customer

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe(TM)”), a provider of next-generation transdermal alcohol detection solutions, today announced that the Oglala Lakota Nation is adopting the SOBRcheck(TM) technology for use in its community-wide probation management program. The Oglala Lakota Nation is a self-governing nation within the U.S., and its Pine River Reservation in South Dakota is the eighth-largest Native American reservation in the country. “Our law enforcement function is resource-constrained, so we are always seeking ways to innovate and gain operational efficiencies,” said Warren Cross, lab director, Oglala Sioux Tribe Clinical Lab. “SOBRcheck is faster and cleaner than the legacy breathalyzer method, both…

Continue Reading

ThursdayFeb 29, 2024 10:19 am

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN), Subsidiary Report Positive Clinical Results of CNM-Au8 Treatment at MS Forum

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, and its wholly owned subsidiary Clene Nanomedicine Inc., is reporting on the full clinical results for CNM-Au8(R), an investigational first-in-class therapy designed to improve central nervous system cells’ survival and function. Clene, which is focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), presented the results at the ninth annual Americas Committee for Treatment and Research in Multiple Sclerosis Forum in Florida. The results were gathered from the VISIONARY-MS trial long-term open label extension (“LTE”) in participants with stable…

Continue Reading

ThursdayFeb 29, 2024 10:00 am

NetworkNewsBreaks – Ocean Biomedical Inc.’s (NASDAQ: OCEA) Joint Venture Partner to Present First Clinical Study Data at 33rd Annual Meeting of APASL

Ocean Biomedical (NASDAQ: OCEA), a biopharma company that endeavors to accelerate the development of compelling discoveries from top research scientists, congratulates its joint venture partner, Virion Therapeutics, LLC, a clinical-stage biotechnology company developing T cell-based immunotherapies, for the acceptance of its abstract highlighting the first-ever human data from its novel checkpoint modifier immunotherapy for HBV functional cure. The abstract was accepted for late breaker oral presentation at the 33rd Annual Meeting of APASL (The Asian Pacific Association for the Study of the Liver), taking place in Kyoto, Japan, from March 27-31, 2024. “This accepted abstract highlights Virion’s commitment to finding…

Continue Reading

ThursdayFeb 29, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO to Participate at Upcoming Sixth International Congress on Controversies in Fibromyalgia

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, will be featured at the upcoming Sixth International Congress on Controversies in Fibromyalgia. The event is scheduled for March 7, 2024, in Brussels, Belgium. During the one-day event, Tonix Pharmaceuticals CEO Seth Lederman, MD, is slated to present. During his presentation, Lederman will provide an overview of data from the recently reported positive phase 3 RESILIENT trial of Tonmya(TM) (also known as TNX-102 SL) for the management of fibromyalgia. To view the full press release, visit https://nnw.fm/s110j About Tonix Pharmaceuticals Holding Corp. Tonix is…

Continue Reading

WednesdayFeb 28, 2024 2:59 pm

NetworkNewsBreaks – Acri Capital Acquisition Corporation (NASDAQ: ACACU), Foxx Development Inc. Enter Business Combination Agreement

Acri Capital (NASDAQ: ACAC, ACACU, ACACW), a Delaware incorporated special purpose acquisition company listed on the Nasdaq Global Market, and Foxx Development Inc., a Texas-based consumer electronics and integrated Internet-of-Things (“IoT”) solution company, have announced their entry into a definitive business combination agreement. Under the agreement, a newly established subsidiary of Acri will become a publicly listed company combining Acri and Foxx (the “combined company”) upon the closing of the transaction, with expected listing of its common stock on the Nasdaq. “Acri’s inception revolved around the goal of identifying and partnering with companies led by visionary, mission-oriented leadership teams who…

Continue Reading

WednesdayFeb 28, 2024 2:49 pm

NetworkNewsBreaks – HealthLynked Corp. (HLYK) Announces Strategic Appointment of Garrett Gardi

HealthLynked (OTCQB: HLYK), a leader in health care technology solutions for patients and providers, has announced the addition of Garrett Gardi to its advisory board. Gardi has more than two decades of experience in employee benefit plans, specializing in predictive cost analytics, consumer-driven platforms, and self-funded/alternative funding methodologies, and brings a wealth of knowledge and expertise to the HealthLynked team. “Garrett’s addition to our advisory board marks a significant milestone for HealthLynked as we continue to expand our reach and impact in the health care sector,” said Dr. Michael Dent, CEO of HealthLynked. “His extensive experience and innovative approach to…

Continue Reading

WednesdayFeb 28, 2024 2:38 pm

NetworkNewsBreaks – Software Effective Solutions Corp.’s (SFWJ) Columbia-Based Subsidiary Names Agri-Tech Leader as Sales Director

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) today announced that Eko2o S.A.S., a majority controlled subsidiary of MedCana in Colombia and a leading provider of greenhouse infrastructure and agricultural technology, has appointed Paula Restrepo as its new sales director. With a career spanning over nine years as a technical representative for a prominent technology company in the Colombian flower industry, Restrepo brings a wealth of experience and a fresh perspective to the EKO2O team. Restrepo’s extensive background in agricultural technology and deep understanding of the Colombian market make her an invaluable asset. “We are thrilled to welcome Paula Restrepo to…

Continue Reading